An optimization model for antibiotic use

Applied Mathematics and Computation

Volumn 201, Issue 1-2, 2008, Pages 161-167

  Massad, Eduardo ^a,b   Burattini, Marcelo Nascimento ^a   Coutinho, Francisco Antonio Bezerra ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antibiotics; Evolution of resistance; Mathematical model; Optimization

Indexed keywords

BACTERIA; CORRELATION METHODS; DISEASE CONTROL; MATHEMATICAL MODELS; OPTIMIZATION; PATIENT MONITORING;

EVOLUTION OF RESISTANCE; HOSPITALIZATION TIME; MORTALITY RATES;

ANTIBIOTICS;

EID: 44649121618     PISSN: 00963003     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amc.2007.12.007     Document Type: Article

References (30)

1. Walsh C. Antibiotics: Actions, Origins, Resistance (2003), ASM Press, Washington, DC
2. Amyes S.G.B. Magic Bullets, Lost Horizons: The Rise and Fall of Antibiotics (2001), Taylor Francis, New York
3. Levy S.B. The challenge of antibiotic resistance. Scientific American 278 (1998) 45-53
4. Hsue P.R., Chen W.H., and Luh K.T. Relationship between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991 to 2003 at a university hospital in Taiwan. International Journal of Antimicrobial Agents 26 (2005) 463-472
5. Archibald L., Philips L., Monnet D., McGowan Jr. J.E., Tenover F., and Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clinical Infectious Diseases 24 2 (1997) 211-215
6. Flamm R.K., Weaver M.K., Thornsberry C., Jones M.E., Karlowsky J.A., and Sahm D.F. Factors associated with relative rates of antibiotic resistance Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrobial Agents and Chemotherapy 48 7 (2004) 2431-2436
7. Rhomberg P.R., Jones R.N., Sader H.S., and Fritsche T.R. Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres. International Journal of Antimicrobial Agents 23 1 (2004) 52-59
8. Sader H.S., Biedenbach D.J., and Jones R.N. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). Diagnostic Microbiology and Infectious Disease 47 1 (2003) 361-364
9. S. Malhotra-Kumar, C. Lammens, S. Coenen, Van K. Herck, H. Gossens, Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomized, double-blind, placebo-controlled study, 2007.
10. Gossens H., Ferech M., Vander S.R., and Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 579-587
11. Palumbi S.R. Humans as the world's greatest evolutionary force. Science 293 (2001) 1786-1790
12. Jumber N., Loui A., Leary R., Liu W., Deziel M.R., Tam V.H., Bachhawat R., Freeman C., Kahn J.B., Bush K., Dudley M.N., Miller M.H., and Drusano G.L. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial population during therapy. The Journal of Clinical Investigation 112 (2003) 275-285
13. Lipsitch M., and Samore M.H. Antimicrobial use and antimicrobial resistance: a population perspective. Emerging Infectious Diseases 8 4 (2002) 347-354
14. Opal S.M., and Medeiros A.A. Molecular mechanisms of antibiotic resistance in bacteria. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases. sixth ed. (2005), Elsevier Churchill Livingstone, Philadelphia 253-270 (Chapter 17)
15. Medeiros A.A. Evolution and dissemination of β-lactamases acelerated by generations of β-lactam antibiotics. Clinical Infectious Diseases 24 (1997) S19-S45
16. Woodford N., and Ellington M.J. The emergence of antibiotic resistance by mutation. Clinical Microbiology and Infection 13 (2006) 5-18
17. Kopecko D. Specialized genetic recombination systems in bacteria: their involvement in gene expression and evolution. Progress in Molecular and Subcellular Biology 7 (1980) 135-243
18. Roberts M.C., and Kenny G.E. Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antomicrobial Agents and Chemotherapy 29 (1986) 350-352
19. Morse S.A., Johnson S.R., Biddle J.W., and Roberts M.C. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antomicrobial Agents and Chemotherapy 30 (1986) 664-670
20. Papadopoulou B., and Courvalin P. Dispersal in Campylobacter sp. of aphA-3, a kanamycin resistance determinant from gram-positive cocci. Antomicrobial Agents and Chemotherapy 32 (1988) 945-948
21. Lupski J.R. Molecular mechanisms for transposition of drug resistance genes and other movable genetic elements. Review of Infectious Diseases 9 (1987) 357-368
22. Tran J.H., and Jacoby G.A. Mechanisms of plasmid-mediated quinolone resistance. Proceedings of the National Academy of Sciences USA 99 (2002) 5638-5642
23. Chang S., Sievert D.M., Hageman J.C., Boulton M.L., Tenover F.C., Downes F.P., Shah S., and Fridkin S.K. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. New England Journal of Medicine 348 14 (2003) 1342-1347
24. Galimand M., Guiyoule A., Gerbaud G., Rasoamanana B., Chanteau S., Carniel E., and Courvalin P. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. New England Journal of Medicine 337 10 (1997) 677-680
25. Laxminarayan R. Economics of antibiotic resistance: a theory of optimal use. Journal of Environmental Economics and Management 42 (2001) 183-206
26. McGowan J.E. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Review of Infectious Diseases 5 (1983) 1033-1048
27. Massad E., Lundberg S., and Yang H.M. Modeling and simulating the evolution of resistance against antibiotics. International Journal of Biomedical Computing 33 (1993) 65-81
28. Lipsitch M., and Levin B.R. The population dynamics of antimicrobial chemotherapy. Antimicrobial Agents and Chemotherapy 41 2 (1997) 363-373
29. D.J. Austin, R.M. Anderson, Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models, 1999.
30. Levin B.R. Minimizing potential resistance: a population dynamics view. Clinical Infectious Diseases 33 Suppl. 3 (2001) S161-S169